Functionalizing αvβ3- or α5β1-selective integrin antagonists for surface coating: A method to discriminate integrin subtypes in vitro

Angewandte Chemie - International Edition

Volumn 52, Issue 5, 2013, Pages 1572-1575

  Rechenmacher, Florian ^a   Neubauer, Stefanie ^a   Polleux, Julien ^d   Mas Moruno, Carlos ^a   De Simone, Mariarosaria ^a   Cavalcanti Adam, Elisabetta Ada ^b,e   Spatz, Joachim P ^b,e   Fässler, Reinhard ^d   Kessler, Horst ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^e MAX PLANCK INSTITUTE FOR INTELLIGENT SYSTEMS   (Germany)

Author keywords

cell adhesion; gold nanoarrays; integrin antagonists; peptide mimetics; surface coatings

Indexed keywords

FUNCTIONALIZED; GENETICALLY MODIFIED; IN-VITRO; INTEGRIN LIGANDS; INTEGRINS; NANOARRAYS; NANOSTRUCTURED GOLD; PEPTIDE MIMETICS; SURFACE COATINGS;

CELL ADHESION; CELL CULTURE; GOLD;

COATINGS;

GOLD; LIGAND; METAL NANOPARTICLE; PEPTIDOMIMETIC AGENT; THIOL DERIVATIVE; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN RECEPTOR;

ANIMAL; ARTICLE; CELL ADHESION; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; METABOLISM; MOUSE; SURFACE PROPERTY;

ANIMALS; CELL ADHESION; CELL LINE; GOLD; INTEGRIN ALPHA5BETA1; INTEGRIN ALPHAVBETA3; LIGANDS; METAL NANOPARTICLES; MICE; PEPTIDOMIMETICS; SULFHYDRYL COMPOUNDS; SURFACE PROPERTIES;

EID: 84872849297     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201206370     Document Type: Article

References (46)

1. M. D. Pierschbacher, E. Ruoslahti, Nature 1984, 309, 30-33.
2. C. J. Avraamides, B. Garmy-Susini, J. A. Varner, Nat. Rev. Cancer 2008, 8, 604-617.
3. R. O. Hynes, Cell 2002, 110, 673-687.
4. R. O. Hynes, Nat. Med. 2002, 8, 918-921.
5. M. Arnold, E. A. Cavalcanti-Adam, R. Glass, J. Blümmel, W. Eck, M. Kantlehner, H. Kessler, J. P. Spatz, ChemPhysChem 2004, 5, 383-388.
6. B. Geiger, J. P. Spatz, A. D. Bershadsky, Nat. Rev. Mol. Cell Biol. 2009, 10, 21-33.
7. R. Zaidel-Bar, S. Itzkovitz, A. Ma′ayan, R. Iyengar, B. Geiger, Nat. Cell Biol. 2007, 9, 858-868.
8. S. L. Goodman, M. Picard, Trends Pharmacol. Sci. 2012, 33, 405-412.
9. E. Ruoslahti, Nat. Rev. Cancer 2002, 2, 83-90.
10. B. G. Keselowsky, D. M. Collard, A. J. Garcia, J. Biomed. Mater. Res. Part A 2003, 66A, 247-259
11. B. G. Keselowsky, D. M. Collard, A. J. Garcia, Proc. Natl. Acad. Sci. USA 2005, 102, 5953-5957
12. E. A. Cavalcanti-Adam, T. Volberg, A. Micoulet, H. Kessler, B. Geiger, J. P. Spatz, Biophys. J. 2007, 92, 2964-2974
13. M. Arnold, V. C. Hirschfeld-Warneken, T. Lohmüller, P. Heil, J. Blümmel, E. A. Cavalcanti-Adam, M. Lopéz-García, P. Walther, H. Kessler, B. Geiger, J. P. Spatz, Nano Lett. 2008, 8, 2063-2069
14. J. H. Huang, S. V. Graeter, F. Corbellini, S. Rinck, E. Bock, R. Kemkemer, H. Kessler, J. D. Ding, J. P. Spatz, Nano Lett. 2009, 9, 1111-1116
15. S. H. Shabbir, J. L. Eisenberg, M. Mrksich, Angew. Chem. 2010, 122, 7872-7875
16. Angew. Chem. Int. Ed. 2010, 49, 7706-7709
17. K. A. Kilian, M. Mrksich, Angew. Chem. 2012, 124, 4975-4979
18. Angew. Chem. Int. Ed. 2012, 51, 4891-4895.
19. E. F. Plow, T. K. Haas, L. Zhang, J. Loftus, J. W. Smith, J. Biol. Chem. 2000, 275, 21785-21788.
20. S. P. Massia, J. A. Hubbell, J. Cell Biol. 1991, 114, 1089-1100
21. D. J. Irvine, A. V. G. Ruzette, A. M. Mayes, L. G. Griffith, Biomacromolecules 2001, 2, 545-556
22. U. Hersel, C. Dahmen, H. Kessler, Biomaterials 2003, 24, 4385-4415
23. W. Kuhlman, I. Taniguchi, L. G. Griffith, A. M. Mayes, Biomacromolecules 2007, 8, 3206-3213
24. Y. Ohmuro-Matsuyama, Y. Tatsu, Angew. Chem. 2008, 120, 7637-7639
25. Angew. Chem. Int. Ed. 2008, 47, 7527-7529
26. J. Sánchez-Cortés, M. Mrksich, Chem. Biol. 2009, 16, 990-1000
27. J. Sánchez-Cortés, M. Mrksich, ACS Chem. Biol. 2011, 6, 1078-1086
28. B. F. Bell, M. Schuler, S. Tosatti, M. Textor, Z. Schwartz, B. D. Boyan, Clin. Oral Impl. Res. 2011, 22, 865-872.
29. M. A. Dechantsreiter, E. Planker, B. Mathä, E. Lohof, G. Hölzemann, A. Jonczyk, S. L. Goodman, H. Kessler, J. Med. Chem. 1999, 42, 3033-3040
30. C. Mas-Moruno, F. Rechenmacher, H. Kessler, Anti-Cancer Agents Med. Chem. 2010, 10, 753-768
31. S. L. Goodman, G. Hölzemann, G. A. G. Sulyok, H. Kessler, J. Med. Chem. 2002, 45, 1045-1051
32. R. Stragies, F. Osterkamp, G. Zischinsky, D. Vossmeyer, H. Kalkhof, U. Reimer, G. Zahn, J. Med. Chem. 2007, 50, 3786-3794.
33. D. Heckmann, A. Meyer, L. Marinelli, G. Zahn, R. Stragies, H. Kessler, Angew. Chem. 2007, 119, 3641-3644
34. Angew. Chem. Int. Ed. 2007, 46, 3571-3574
35. D. Heckmann, B. Laufer, L. Marinelli, V. Limongelli, E. Novellino, G. Zahn, R. Stragies, H. Kessler, Angew. Chem. 2009, 121, 4501-4506
36. Angew. Chem. Int. Ed. 2009, 48, 4436-4440.
37. D. Heckmann, A. Meyer, B. Laufer, G. Zahn, R. Stragies, H. Kessler, ChemBioChem 2008, 9, 1397-1407.
38. C. Dahmen, J. Auernheimer, A. Meyer, A. Enderle, S. L. Goodman, H. Kessler, Angew. Chem. 2004, 116, 6818-6821
39. Angew. Chem. Int. Ed. 2004, 43, 6649-6652.
40. J.-P. Xiong, T. Stehle, R. Zhang, A. Joachimiak, M. Frech, S. L. Goodman, M. A. Arnaout, Science 2002, 296, 151-155.
41. L. Marinelli, A. Meyer, D. Heckmann, A. Lavecchia, E. Novellino, H. Kessler, J. Med. Chem. 2005, 48, 4204-4207.
42. L. A. Carpino, G. Y. Han, J. Org. Chem. 1972, 37, 3404-3409.
43. R. B. Merrifield, J. Am. Chem. Soc. 1963, 85, 2149-2154.
44. A. O. Frank, E. Otto, C. Mas-Moruno, H. B. Schiller, L. Marinelli, S. Cosconati, A. Bochen, D. Vossmeyer, G. Zahn, R. Stragies, E. Novellino, H. Kessler, Angew. Chem. 2010, 122, 9465-9468
45. Angew. Chem. Int. Ed. 2010, 49, 9278-9281.
46. J. C. Love, L. A. Estroff, J. K. Kriebel, R. G. Nuzzo, G. M. Whitesides, Chem. Rev. 2005, 105, 1103-1169.